Laserfiche WebLink
HF100 NINTH ENGROSSMENT REVISOR BD 1-10100-9 <br />111.1 (2) agree to only possess the patient's medical cannabis flower and medical cannabinoid <br />111.2 products for purposes of assisting the patient; and <br />111.3 (3) agree that if the application is approved, the person will not serve as a registered <br />111.4 designated caregiver for more than six registered patients at one time. Patients who reside <br />111.5 in the same residence count as one patient. <br />111.6 (c) The office shall conduct a criminal background check on the designated caregiver <br />111.7 prior to registration to ensure that the person does not have a conviction for a disqualifying <br />111.8 felony offense. Any cost of the background check shall be paid by the person seeking <br />i 11.9 registration as a designated caregiver. A designated caregiver must have the criminal <br />i i i . i o background check renewed every two years. <br />111.11 (d) Nothing in this section shall be construed to prevent a registered designated caregiver <br />111.12 from being enrolled in the registry program as a patient and possessing and administering <br />111.13 medical cannabis flower or medical cannabinoid products as a patient. <br />111.14 Subd. 10. Parents, legal guardians, spouses. A parent, legal guardian, or spouse of a <br />111.15 patient may act as the caregiver for a patient. The parent, legal guardian, or spouse who is <br />111.16 acting as a caregiver must follow all requirements for parents, legal guardians, and spouses <br />111.17 under this chapter. Nothing in this section limits any legal authority that a parent, legal <br />111.1 s guardian, or spouse may have for the patient under any other law. <br />111.19 Subd. 11. Notice of change of name or address. Patients and registered designated <br />111.20 caregivers must notify the Division of Medical Cannabis of any address or name change <br />111.21 within 30 days of the change having occurred. A patient or registered designated caregiver <br />111.22 is subject to a $100 fine for failure to notify the office of the change. <br />111.23 EFFECTIVE DATE. This section is effective January 1, 2024. <br />111.24 Sec. 53. [342.53] DUTIES OF OFFICE OF CANNABIS MANAGEMENT; <br />111.25 REGISTRY PROGRAM. <br />111.26 The office may add an allowable form of medical cannabinoid product, and may add or <br />111.27 modify a qualifying medical condition upon its own initiative, upon a petition from a member <br />111.28 of the public or from the Cannabis Advisory Council or as directed by law. The office must <br />111.29 evaluate all petitions and must make the addition or modification if the office determines <br />111.30 that the addition or modification is warranted by the best available evidence and research. <br />111.31 If the office wishes to add an allowable form or add or modify a qualifying medical condition, <br />111.32 the office must notify the chairs and ranking minority members of the legislative committees <br />111.33 and divisions with jurisdiction over health finance and policy by January 15 of the year in <br />Article 1 Sec. 53. 111 <br />